Clinical Trials Browser

Recruiting × OTHER × Gestational Trophoblastic Disease × Clear all

NCT03785574 2026-03-16

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Phase NA Recruiting

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT06339827 2025-06-18

ASQ-GYO

Phase NA Recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

NCT06169644 2025-02-21

PI-GTN

Disease, Neoplasms, Gestational Trophoblastic Disease

NCT06028672 2025-02-06

TA56

Phase NA Recruiting

Gestational Trophoblastic Disease

NCT06020755 2024-12-31

TA7

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT06681259 2024-11-12

Clinical Specialty Queue For Gestational Trophoblastic Neoplasia

Gestational Trophoblastic Disease

NCT05635344 2024-04-17

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Recurrence, Gestational Trophoblastic Disease

NCT02892877 2016-09-08

French GTDC

25,500 enrolled

Hydatidiform Mole, Invasive, Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Trophoblastic Tumor, Placental Site, Gestational Trophoblastic Disease